سیدمحسن اصغری

1. Enhanced antitumor activity of lapatinib against triple-negative breast cancer via loading in human serum albumin

Rostaminasab Sadegh، Esmaeili Alireaza، موسوی موحدی فائزه، Moosavi Movahhedi Ali Akbar، Memarkashani Sahar، Rezaei Rudmianeh Havva، Shourian Mostafa، Shafiee Ardestani Mehdi، Asghari Seyedmohsen (2024)., International Journal of Biological Macromolecules, 282(136760), 136760.

2. Novel Gd-DTPA-peptide for targeted breast tumor magnetic resonance imaging

Reisi Zargari Nooshin، Ebrahimi Fatemeh، Akhlaghi Mehdi، Beiki Davood، Abdi Khosrou، Abbas Mohammad Amin، Ramezanpour Sorour، Asghari Seyedmohsen (2024)., BIOMEDICINE & PHARMACOTHERAPY, 178(1), 117189.

3. PEGylated Pemetrexed and PolyNIPAM Decorated Gold Nanoparticles: A Biocompatible and Highly Stable CT Contrast Agent for Cancer Imaging

Mohajer Mohammad، Salehi Peyman، Heidari Bahareh، Rafati Hasan، Asghari Seyedmohsen، Behboudi Hossein، Iranpour Pooya (2024)., ACS Applied Bio Materials, 7(8).

4. Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer

Ebrahimi Fatemeh، Reisi Zargari Nooshin، Akhlaghi Mehdi، Asghari Seyedmohsen، Abdi Khosrou، Balalaie Saeed، Asadi Mahboobeh، Beiki Davood (2024)., Pharmaceutics, 16(7), 899.

1. Gold nanoparticle conjugation and tumor accumulation of a VEGF receptor-targeting peptidomimetic

Navidi Moghadam Foumani Reza، Fazilati Mohammad، Shafiee Ardestani Mehdi، Zanjanchi Pegah، Asghari Seyedmohsen (2023)., Journal of the Iranian Chemical Society, 20(1).

2. Design, Synthesis, and Functional Studies on Noscapine and Cotarnine Amino Acid Derivatives as Antitumor Agents

Davarzani Zahra، Salehi Peyman، Asghari Seyedmohsen، Bararjanian Morteza، Hamrahi Mohsen Ali، Dehghan Harati Helia (2023)., ACS Omega, 8(48), 45502-45509.

3. Improvement of Breast Tumor Imaging by Multifunctional SPION Nanoparticles Conjugated with a Novel Engineered Endostatin Peptide

Mahdavimehr Mohsen، Rahdari Tahereh، Ramezanpour Sorour، Asghari Seyedmohsen (2023)., 6th international TPCF Preclinical Imaging Symposium (TPIS2023), 8-9 November, Tehran, Iran.

4. MRI Contrast Agents: Advancements in Breast Cancer Imaging and Early Diagnosis

Reisi Zargari Nooshin، Ebrahimi Fatemeh، Asghari Seyedmohsen، Akhlaghi Mehdi، Beiki Davood، Ramezanpour Sorour (2023)., 6th international TPCF Preclinical Imaging Symposium (TPIS2023), 8-9 November, Tehran, Iran.

6. Vascular endothelial growth factor antagonist peptides inhibit tumor growth and metastasis in breast cancer through repression of c-src and STAT3 genes

Bejari Maedeh، Talesh Sasani Soheila، Asghari Seyedmohsen، Nabatzade Kolshan Mozhgan (2023)., MOLECULAR BIOLOGY REPORTS, 50(11).

7. Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari Sedigheh، Rezayof Ameneh، Asghari Seyedmohsen، Hashemizadeh Shiva (2023)., Neuropeptides, 101(102356), 102356.

9. A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities

Namjoo Mohadeseh، Ghafouri Hossein، Assareh Elham، Aref Amir Reza، Mostafavi Ebrahim، Hamrahi Mohsen Ali، Balalaie Saeed، Broussy Sylvain، Asghari Seyedmohsen (2023)., Pharmaceuticals, 16(6), 906.

10. Extracellular vesicle-derived non-coding RNAs (EV-ncRNAs) and their multifaceted roles in cancer biology

Neamati Nahid، Al-e-Ahmad Atiyeh، Yeganeh Farshid، Asghari Seyedmohsen، Parsian Hadi (2023)., Frontiers in Oncology, 13(1), 1185363.

2. A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics

Assareh Elham، Abbasi Mohammad Amin، Heidari Mahsa، Asghari Seyedmohsen (2023)., IRANIAN JOURNAL OF SCIENCE, 47(1), 325-325.

4. Functional evaluation of a novel kisspeptin analogue on the reproduction of female goldfish

Rabouti Hanieh، Asghari Seyedmohsen، Sariri Reihaneh، Balalaie Saeed، Valipour AbdolMajid، Omidian Navid، Heidari Behrooz (2022)., Scientific Reports, 12(1), 21944.

5. Design and recombinant production of GFP-VEGF receptor binding peptide and its tumor targeting ability

Ghajari Yasaman، Jafarian Vahab، Asghari Seyedmohsen، H. Sajedi Reza (2022)., 17th National and 2nd International Conference of Iranian Biophysical Chemistry, 6-7 September, Rasht, Iran.

6. Design, cloning, expression and purification of SUMO-endostatin fusion peptide in Escherichia coli

Derakhshan-Raad Mahboubeh، Asghari Seyedmohsen، Aminzadeh Saeed، H. Sajedi Reza (2022)., 17th National and 2nd International Conference of Iranian Biophysical Chemistry, 6-7 September, Rasht, Iran.

7. Design, cloning, expression, and purification of a fusion peptide derived from human endostatin

Derakhshan-Raad Mahboubeh، H. Sajedi Reza، Aminzadeh Saeed، Asghari Seyedmohsen (2022)., 17th National Congress of Biochemistry and 8th International Congress of Biochemistry and Molecular Biology, 23-26 August, Tehran, Iran.

8. Anti-tumor and anti-metastatic activity of the FGF2 118–126 fragment dependent on the loop structure

Allahmoradi Hossein، Asghari Seyedmohsen، Assareh Elham، Nazari Mahboobeh، Ahmadi Atieh (2022)., BIOCHEMICAL JOURNAL, 479(12), 1285-1302.

1. Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways

Farzaneh Behelgardi Maryam، Gholami Shahvir Zahra، Asghari Seyedmohsen (2022)., MOLECULAR BIOLOGY REPORTS, 49(5), 3637-3647.

2. Investigation of binding lapatinib to albumin nanoparticles by FTIR

Ramzanpoor Marziyeh، Asghari Seyedmohsen، Shourian Mostafa (2022)., 1st International and 3rd National Conference on Biomathematics, 19-21 January, Damghan, Iran.

3. FTIR analysis of antiangiogenesis peptide binding to human serum albumi

Amini Zainab، Shourian Mostafa، Asghari Seyedmohsen (2022)., 1st International and 3rd National Conference on Biomathematics, 19-21 January, Damghan, Iran.